SARS-CoV-2’s evolutionary capacity is mostly driven by host antiviral molecules
暂无分享,去创建一个
M. Cotten | R. Orton | Martha M Luka | M. Phan | D. Robertson | Kieran D. Lamb | Megan Saathoff | Ke Yuan | David L. Robertson | Kieran D Lamb
暂无分享,去创建一个
M. Cotten | R. Orton | Martha M Luka | M. Phan | D. Robertson | Kieran D. Lamb | Megan Saathoff | Ke Yuan | David L. Robertson | Kieran D Lamb